Home » Topics » BioWorld Science

BioWorld Science
RSS

Gilead reports important discovery related to genetic code blocker research

July 5, 1996

Eotaxin receptor cloned: Possible implications for asthma research

July 5, 1996

Anergen, Organon to collaborate on RA treatment

July 5, 1996

ArQule obtains rights to Yale's alpha-ketoamide chemistry technology

July 5, 1996

Mitotix in-licenses p27 technology

July 5, 1996

Telomere length may reflect disease progression in AIDS patients

July 5, 1996

RiboGene licenses anti-HIV compounds from Warner-Lambert

July 5, 1996

Sumitomo claims psychotropic lactam derivatives

July 5, 1996

5-HT2 ligands claimed by Janssen

July 5, 1996

Anxiolytic/antidepressant 5-HT1A receptor ligands from AHP

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...